blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1731140

EP1731140 - Medicinal aerosol formulation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.02.2012
Database last updated on 24.04.2024
Most recent event   Tooltip11.07.2014Lapse of the patent in a contracting state
New state(s): ES
published on 13.08.2014  [2014/33]
Applicant(s)For all designated states
Aeropharm Technology Incorporated
Raritan Center, Campus Plaza, 18 Mayfield Avenue
Edison, NJ 08818 / US
[2006/50]
Inventor(s)01 / Adjei, Akwete
15 Tillman Court
Bridgewater NJ 08807 / US
02 / Cutie, Anthony J.
P.O. Box 6725
Bridgewater NJ 08807 / US
 [2006/50]
Representative(s)Forstmeyer, Dietmar, et al
Boeters & Lieck
Oberanger 32
80331 München / DE
[N/P]
Former [2008/35]Forstmeyer, Dietmar, et al
BOETERS & LIECK Oberanger 32
80331 München / DE
Former [2006/50]Forstmeyer, Dietmar, et al
BOETERS & LIECK Oberanger 32
80331 München / DE
Application number, filing date06016853.117.09.1999
[2006/50]
Priority number, dateUS1998015836922.09.1998         Original published format: US 158369
[2006/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1731140
Date:13.12.2006
Language:EN
[2006/50]
Type: A3 Search report 
No.:EP1731140
Date:27.06.2007
[2007/26]
Type: B1 Patent specification 
No.:EP1731140
Date:13.04.2011
Language:EN
[2011/15]
Search report(s)(Supplementary) European search report - dispatched on:EP25.05.2007
ClassificationIPC:A61K9/12
[2006/50]
CPC:
A61K9/008 (EP,US); A61K47/183 (EP,US); A61K47/20 (EP,US);
A61P11/00 (EP); A61P11/06 (EP); A61P11/08 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2006/50]
TitleGerman:Medizinische Aerosolformulierung[2006/50]
English:Medicinal aerosol formulation[2006/50]
French:Formulation d'aerosol medicinal[2006/50]
Examination procedure07.11.2007Examination requested  [2007/51]
20.12.2007Despatch of a communication from the examining division (Time limit: M04)
03.04.2008Reply to a communication from the examining division
26.08.2008Despatch of a communication from the examining division (Time limit: M04)
17.12.2008Reply to a communication from the examining division
26.10.2010Communication of intention to grant the patent
28.02.2011Fee for grant paid
28.02.2011Fee for publishing/printing paid
Parent application(s)   TooltipEP99946974.5  / EP1123120
Opposition(s)16.01.2012No opposition filed within time limit [2012/12]
Fees paidRenewal fee
28.08.2006Renewal fee patent year 03
28.08.2006Renewal fee patent year 04
28.08.2006Renewal fee patent year 05
28.08.2006Renewal fee patent year 06
28.08.2006Renewal fee patent year 07
28.09.2006Renewal fee patent year 08
05.09.2007Renewal fee patent year 09
27.03.2008Renewal fee patent year 10
04.09.2009Renewal fee patent year 11
07.09.2010Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT13.04.2011
BE13.04.2011
CY13.04.2011
DK13.04.2011
ES13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
IE17.09.2011
LU17.09.2011
CH30.09.2011
FR30.09.2011
LI30.09.2011
MC30.09.2011
[2014/33]
Former [2013/25]AT13.04.2011
BE13.04.2011
CY13.04.2011
DK13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
IE17.09.2011
LU17.09.2011
CH30.09.2011
FR30.09.2011
LI30.09.2011
MC30.09.2011
Former [2012/37]AT13.04.2011
BE13.04.2011
CY13.04.2011
DK13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
IE17.09.2011
CH30.09.2011
FR30.09.2011
LI30.09.2011
MC30.09.2011
Former [2012/35]AT13.04.2011
BE13.04.2011
CY13.04.2011
DK13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
IE17.09.2011
CH30.09.2011
LI30.09.2011
MC30.09.2011
Former [2012/33]AT13.04.2011
BE13.04.2011
CY13.04.2011
DK13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
CH30.09.2011
LI30.09.2011
MC30.09.2011
Former [2012/20]AT13.04.2011
BE13.04.2011
CY13.04.2011
DK13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
MC30.09.2011
Former [2012/10]AT13.04.2011
BE13.04.2011
CY13.04.2011
DK13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
Former [2012/02]AT13.04.2011
BE13.04.2011
CY13.04.2011
FI13.04.2011
NL13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
Former [2012/01]AT13.04.2011
BE13.04.2011
CY13.04.2011
FI13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
Former [2011/49]CY13.04.2011
FI13.04.2011
SE13.04.2011
GR14.07.2011
PT16.08.2011
Former [2011/47]PT16.08.2011
Documents cited:Search[X]WO9009781  (RORER INT OVERSEAS [US]) [X] 1,2,5,8-16,19,20 * page 1 * * page 5 * * page 25 - page 29; example - * * claim - *;
 [X]WO9619198  (ASTRA AB [SE], et al) [X] 1-6,8-20 * page 1, line 10 - line 31 * * page 2, line 9 - line 25 * * page 3, line 26 - line 30 * * page 5, line 5 - line 31 * * example - * * claim 3 *;
 [A]WO9632096  (INHALE THERAPEUTIC SYST [US], et al) [A] 1-20 * page 4, line 23 - line 32 * * page 8, line 1 - line 16 * * page 9, line 3 - line 23 * * page 10, line 20 - line 30 ** page 15, line 1 - page 16, line 5 *;
 [X]US5569450  (DUAN DANIEL C [US], et al) [X] 1-4,7-9,11-18 * column 1, line 44 - line 67 * * column 2, line 5 - line 31 * * column 3, line 39 - line 46 * * column 4, line 40 - line 44 * * column 8, line 15 - line 34 * * examples F,1-13; table - * * claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.